scholarly article | Q13442814 |
P356 | DOI | 10.1159/000339488 |
P8608 | Fatcat ID | release_2ygivsntgfbj7b2mpobhx2lwny |
P698 | PubMed publication ID | 22832033 |
P2093 | author name string | Ingo B Autenrieth | |
Sabine Gröbner | |||
Yvonne Pfeifer | |||
Matthias Marschal | |||
Patrick Weissgerber | |||
Matthias Wienke | |||
P2860 | cites work | Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany | Q33469945 |
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions | Q34720052 | ||
CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem | Q34973754 | ||
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system | Q35065875 | ||
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy | Q36870786 | ||
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam | Q37043641 | ||
Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain | Q37576488 | ||
Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. | Q37671098 | ||
Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact | Q37770996 | ||
Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections | Q37811723 | ||
Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany | Q39973074 | ||
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting | Q39991540 | ||
Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae | Q41269079 | ||
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials | Q41813766 | ||
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. | Q42054872 | ||
Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae | Q42165204 | ||
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline | Q42549433 | ||
Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany | Q42919287 | ||
Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in Germany | Q43732434 | ||
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases | Q44706480 | ||
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. | Q45119838 | ||
Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. | Q45972088 | ||
Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases | Q46369724 | ||
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy | Q46855384 | ||
Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK. | Q47598652 | ||
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. | Q48070401 | ||
Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice. | Q54356662 | ||
Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. | Q54419391 | ||
Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and Toronto | Q59187044 | ||
P433 | issue | 3 | |
P921 | main subject | Germany | Q183 |
Escherichia coli | Q25419 | ||
Klebsiella pneumoniae | Q132592 | ||
P304 | page(s) | 241-248 | |
P577 | publication date | 2012-07-25 | |
P1433 | published in | Chemotherapy | Q2440355 |
P1476 | title | In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany | |
P478 | volume | 58 |
Q38074212 | Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). | cites work | P2860 |
Search more.